MediPharm Labs Corp.
LABS.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.53% | -35.14% | -52.71% | -40.26% | -5.51% |
| Total Receivables | 11.91% | 29.31% | 13.67% | 17.54% | -51.91% |
| Inventory | -14.97% | -3.41% | 1.38% | -20.51% | -11.60% |
| Prepaid Expenses | -22.40% | -14.53% | -29.51% | -38.71% | -25.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -90.57% | -79.60% | 270.04% | 116.17% | 100.73% |
| Total Current Assets | -21.63% | -21.89% | -13.85% | -17.11% | -16.94% |
|
|
|||||
| Total Current Assets | -21.63% | -21.89% | -13.85% | -17.11% | -16.94% |
| Net Property, Plant & Equipment | -11.33% | -7.56% | -27.62% | -30.42% | -22.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -22.24% | -18.69% | -22.79% | -24.05% | -16.52% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -40.23% | -39.26% | -41.72% | -- |
| Total Assets | -19.07% | -17.31% | -19.91% | -22.87% | -17.78% |
|
|
|||||
| Total Accounts Payable | 30.94% | 74.72% | 27.30% | 82.57% | 45.03% |
| Total Accrued Expenses | -56.70% | -47.75% | -47.54% | -16.02% | -3.78% |
| Short-term Debt | -40.38% | -83.35% | -99.34% | -88.75% | -76.78% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.63% | 58.16% | -5.75% | -40.07% | -73.02% |
| Total Finance Division Other Current Liabilities | -16.86% | 13.61% | -11.63% | -17.90% | -35.27% |
| Total Other Current Liabilities | -16.86% | 13.61% | -11.63% | -17.90% | -35.27% |
| Total Current Liabilities | -21.25% | -21.91% | -26.81% | -11.32% | -15.33% |
|
|
|||||
| Total Current Liabilities | -21.25% | -21.91% | -26.81% | -11.32% | -15.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -40.38% | -83.35% | -99.34% | -88.75% | -76.78% |
| Capital Leases | -- | -78.72% | -49.53% | -32.18% | -55.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.51% | -22.13% | -26.92% | -11.46% | -15.58% |
|
|
|||||
| Common Stock & APIC | -2.68% | 0.70% | -5.42% | -7.77% | 0.61% |
| Retained Earnings | 1.48% | -2.31% | 1.89% | 2.66% | -7.01% |
| Treasury Stock & Other | -19.10% | -16.34% | -5.63% | -8.51% | 3.02% |
| Total Common Equity | -18.49% | -16.07% | -18.31% | -25.22% | -18.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.49% | -16.07% | -18.31% | -25.22% | -18.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.49% | -16.07% | -18.31% | -25.22% | -18.29% |
|
|
|||||